Securities Registration: Employee Benefit Plan (s-8)
August 25 2016 - 4:32PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on August 25, 2016
REGISTRATION NO. 333
-
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION
STATEMENT
UNDER
THE SECURITIES ACT OF 1933
ABIOMED, INC.
(Exact Name of Registrant as Specified in Its Charter)
|
|
|
Delaware
|
|
04-2743260
|
(State or Other Jurisdiction
|
|
(I.R.S. Employer
|
of Incorporation or Organization)
|
|
Identification No.)
|
22 Cherry Hill Drive, Danvers, MA 01923
(Address, Including Zip Code, of Principal Executive Offices)
ABIOMED, Inc. Amended & Restated 2015 Omnibus Incentive Plan
(Full Title of the Plan)
Michael R. Minogue
Chief Executive Officer and President
ABIOMED, Inc.
22 Cherry
Hill Drive
Danvers, Massachusetts 01923
(978) 777-5410
(Name,
Address and Telephone Number, Including Area Code, of Agent For Service)
with copies to:
Paul M. Kinsella
Ropes & Gray LLP
Prudential Tower
800
Boylston Street
Boston, Massachusetts 02199
(617) 951-7000
Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting
company in Rule 12b-2 of the Exchange Act. (Check one):
|
|
|
|
|
|
|
Large accelerated filer
|
|
x
|
|
Accelerated filer
|
|
¨
|
|
|
|
|
Non-accelerated filer
|
|
¨
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
¨
|
CALCULATION OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title of securities
to be registered
|
|
Amount
to be
Registered(1)
|
|
Proposed
maximum
offering
price
per share(2)
|
|
Proposed
Maximum
Aggregate
offering price
|
|
Amount of
registration fee
|
Common Stock, $0.01 par value
|
|
1,260,000
|
|
$119.48
|
|
$150,547,950.00
|
|
$15,160.18
|
|
|
(1)
|
This Registration Statement covers the registration of 1,260,000 additional shares Common Stock of ABIOMED, Inc., par value $0.01 per share, authorized for issuance under the ABIOMED, Inc. Amended & Restated
2015 Omnibus Incentive Plan (the 2015 Plan). In addition, pursuant to Rule 416(c) under the Securities Act of 1933, as amended (the Securities Act), this Registration Statement also covers an indeterminate number of
additional shares of ABIOMED, Inc. Common Stock, par value $0.01 per share, that may become issuable pursuant to terms designed to prevent dilution resulting from stock splits, stock dividends or similar events. The Registrant previously filed a
Registration Statement on Form S-8 on August 14, 2015 (File No. 333-206395), which registered 2,000,000 shares of Common Stock of the Registrant for issuance under the 2015 Plan.
|
(2)
|
The offering price for the shares of $ 119.48 per share has been estimated solely for the purpose of determining the registration fee pursuant to Rule 457(c) and (h) of the Securities Act on the basis of the
average high and low prices of ABIOMED, Inc. Common Stock reported on the NASDAQ Global Select Market as of a date (August 24, 2016) within five business days prior to the filing of this Registration Statement.
|
EXPLANTORY NOTE
ABIOMED, Inc. (the Registrant) has prepared this registration statement on Form S-8 (the Registration
Statement) to register an additional 1,260,000 shares of the Registrants common stock, par value $0.01 per share (Common Stock), for issuance under the ABIOMED, Inc. Amended & Restated 2015 Omnibus Incentive Plan.
This Registration Statement is submitted in accordance with General Instruction E to Form S-8 regarding registration of additional securities, and pursuant to such instruction, the contents of the Registration Statement on Form S-8 (File
No. 333-206395) filed with the Securities and Exchange Commission on August 14, 2015 are incorporated herein by reference.
Item 8. Exhibits.
|
|
|
Exhibit
Number
|
|
Description
|
|
|
4.1
|
|
ABIOMED, Inc. Amended & Restated 2015 Omnibus Incentive Plan, (previously filed as Appendix A to the definitive proxy statement on Schedule 14A (File No. 001-09585) on June 30, 2016 and incorporated herein by
reference).
|
|
|
5.1*
|
|
Opinion of Ropes & Gray LLP.
|
|
|
23.1*
|
|
Consent of Independent Registered Public Accounting Firm, Deloitte & Touche LLP.
|
|
|
23.2*
|
|
Consent of Ropes & Gray LLP (included in Exhibit 5.1).
|
|
|
24.1*
|
|
Power of Attorney (included on the signature page in Part II).
|
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the Town of Danvers, Commonwealth of Massachusetts, on the 25
th
day of August, 2016.
|
|
|
ABIOMED, INC.
|
|
|
By:
|
|
/s/ Michael R. Minogue
|
|
|
Michael R. Minogue
|
|
|
President, Chief Executive Officer and Chairman
|
POWER OF ATTORNEY
Each person whose signature appears below constitutes and appoints Michael R. Minogue and Michael J. Tomsicek, and each of them singly, his true and lawful
attorneys-in-fact and agents, with full power of substitution and resubstitution in each of them singly, for him and in his name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to
this Registration Statement on Form S-8 of ABIOMED, Inc., and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting to the attorneys-in-fact and agents, and
each of them, full power and authority to do and perform each and every act and thing requisite or necessary to be done in or about the premises, as full to all intents and purposes as he might or could do in person, hereby ratifying and confirming
all that the attorneys-in-fact and agents or any of each of them or their substitutes may lawfully do or cause to be done by virtue hereof.
Pursuant to
the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
/s/ Michael R. Minogue
Michael R. Minogue
|
|
President, Chief Executive Officer and Chairman (Principal Executive Officer)
|
|
August 25, 2016
|
|
|
|
/s/ Michael J. Tomsicek
Michael J. Tomsicek
|
|
Vice President, Chief Financial Officer and Treasurer
(Principal Financial and Accounting Officer)
|
|
August 25, 2016
|
|
|
|
/s/ Dorothy E. Puhy
Dorothy E. Puhy
|
|
Director
|
|
August 25, 2016
|
|
|
|
/s/ Jeannine M. Rivet
Jeannine M. Rivet
|
|
Director
|
|
August 25, 2016
|
|
|
|
/s/ Eric A. Rose
Eric A. Rose
|
|
Director
|
|
August 25, 2016
|
|
|
|
/s/ Martin P. Sutter
Martin P. Sutter
|
|
Director
|
|
August 25, 2016
|
|
|
|
/s/ Henri A. Termeer
Henri A. Termeer
|
|
Director
|
|
August 25, 2016
|
|
|
|
/s/ Paul Thomas
Paul Thomas
|
|
Director
|
|
August 25, 2016
|
|
|
|
/s/ Christopher D. Van Gorder
Christopher D. Van Gorder
|
|
Director
|
|
August 25, 2016
|
INDEX OF EXHIBITS
|
|
|
Exhibit
Number
|
|
Description
|
|
|
4.1
|
|
ABIOMED, Inc. Amended & Restated 2015 Omnibus Incentive Plan (previously filed as Appendix A to the definitive proxy statement on Schedule 14A (File No. 001-09585) on June 30, 2016 and incorporated herein by
reference).
|
|
|
5.1*
|
|
Opinion of Ropes & Gray LLP.
|
|
|
23.1*
|
|
Consent of Independent Registered Public Accounting Firm, Deloitte & Touche LLP.
|
|
|
23.2*
|
|
Consent of Ropes & Gray LLP (included in Exhibit 5.1).
|
|
|
24.1*
|
|
Power of Attorney (included on the signature page in Part II).
|
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
ABIOMED (NASDAQ:ABMD)
Historical Stock Chart
From Apr 2023 to Apr 2024